Levy A, Lightman S L
Department of Medicine, Charing Cross and Westminster Hospital Medical School, London, United Kingdom.
J Clin Endocrinol Metab. 1989 Jul;69(1):122-6. doi: 10.1210/jcem-69-1-122.
We examined the effects of GnRH and TRH on inositol phospholipid turnover in 11 endocrinologically inactive pituitary adenomas and 5 prolactinomas. In 9 of the 11 nonsecreting adenomas, GnRH induced a significant increase in inositol phospholipid turnover; of those that responded, increased inositol phospholipid turnover in response to TRH occurred in 6. Neither of the 2 prolactinomas exposed to GnRH responded to GnRH, whereas all 5 prolactinomas responded to TRH. These findings demonstrate the presence of functional GnRH receptors on endocrinologically inactive pituitary adenomas. The phosphatidyl inositol-linked receptor status of these tumors differs from that of prolactinomas. These receptors may offer a possible target for therapeutic intervention in endocrinologically inactive adenomas.
我们研究了促性腺激素释放激素(GnRH)和促甲状腺激素释放激素(TRH)对11例无内分泌活性垂体腺瘤和5例催乳素瘤中肌醇磷脂代谢的影响。在11例无分泌功能的腺瘤中,有9例GnRH可显著增加肌醇磷脂代谢;在这些有反应的腺瘤中,有6例对TRH有反应,肌醇磷脂代谢增加。2例暴露于GnRH的催乳素瘤对GnRH均无反应,而所有5例催乳素瘤对TRH均有反应。这些发现表明无内分泌活性垂体腺瘤上存在功能性GnRH受体。这些肿瘤的磷脂酰肌醇连接受体状态与催乳素瘤不同。这些受体可能为无内分泌活性腺瘤的治疗干预提供一个可能的靶点。